GlyCosmos Portal

GlyCosmos PubAnnotations

Recent publication annotations of glycans, cell types, and proteins, from PubAnnotation.

Displaying entries **6301 - 6325** of **24862** in total

« First

‹ Prev

…

249

250

251

252

253

254

255

256

257

…

Next ›

Last »
Title ▼	Authors	PubMed ID	Source	Publication Year
Serum hyaluronidase aberrations in metabolic and morphogenetic disorders.	Fiszer-Szafarz B Czartoryska B Tylki-Szymanska A	16311883	Glycoconj J	2005
Serum glycoproteins in schizophrenia.	Varma R Hoshino AY	7397710	Carbohydr Res	1980
Serum glycome profiling: a biomarker for diagnosis of ovarian cancer.	Biskup K Braicu EI Sehouli J Fotopoulou C Tauber R Berger M Blanchard V	23889230	J Proteome Res	2013
Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain.	MacDonald RG Tepper MA Clairmont KB Perregaux SB Czech MP	2536739	J Biol Chem	1989
Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF-κB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway.	Tomomura M Hasegawa H Suda N Sakagami H Tomomura A	22461633	J Biol Chem	2012
Serum autoantibody profiling using a natural glycoprotein microarray for the prognosis of early melanoma.	Liu Y He J Xie X Su G Teitz-Tennenbaum S Sabel MS Lubman DM	20879797	J Proteome Res	2010
Serum angiotensin-converting enzyme. Isolation and relationship to the pulmonary enzyme.	Das M Hartley JL Soffers RL	190228	J Biol Chem	1977
Serum amyloid P component binding to C4b-binding protein.	García de Frutos P Härdig Y Dahlbäck B	7592941	J Biol Chem	1995
Serum N-glycomics of a novel CDG-IIb patient reveals aberrant IgG glycosylation.	Beimdiek J Hennig R Burock R Puk O Biskup S Rapp E Lesinski-Schiedat A Buettner FFR Das AM	35137040	Glycobiology	2022
Serum N-glycan profiles differ for various breast cancer subtypes.	Vreeker GCM Vangangelt KMH Bladergroen MR Nicolardi S Mesker WE Wuhrer M van der Burgt YEM Tollenaar RAEM	33877489	Glycoconj J	2021
Serum Metabolomics Study of Gliclazide-Modified-Release-Treated Type 2 Diabetes Mellitus Patients Using a Gas Chromatography-Mass Spectrometry Method.	Zhou Y Hu C Zhao X Luo P Lu J Li Q Chen M Yan D Lu X Kong H Jia W Xu G	29460634	J Proteome Res	2018
Serum Metabolome Mediates the Antiobesity Effect of Celastrol-Induced Gut Microbial Alterations.	Xu S Lyu L Zhu H Huang X Xu W Xu W Feng Y Fan Y	34530620	J Proteome Res	2021
Serpin polymerization is prevented by a hydrogen bond network that is centered on his-334 and stabilized by glycerol.	Zhou A Stein PE Huntington JA Carrell RW	12578831	J Biol Chem	2003
Serotype 3 pneumococci sequester platelet-derived human thrombospondin-1 via the adhesin and immune evasion protein Hic.	Binsker U Kohler TP Krauel K Kohler S Habermeyer J Schwertz H Hammerschmidt S	28209711	J Biol Chem	2017
Serotonin (5-Hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle.	Hajduch E Rencurel F Balendran A Batty IH Downes CP Hundal HS	10224126	J Biol Chem	1999
Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling.	Tanti JF Grémeaux T van Obberghen E Le Marchand-Brustel Y	8119950	J Biol Chem	1994
Serine arginine splicing factor 3 is involved in enhanced splicing of glucose-6-phosphate dehydrogenase RNA in response to nutrients and hormones in liver.	Walsh CM Suchanek AL Cyphert TJ Kohan AB Szeszel-Fedorowicz W Salati LM	23233666	J Biol Chem	2013
Serine 474 phosphorylation is essential for maximal Akt2 kinase activity in adipocytes.	Kearney AL Cooke KC Norris DM Zadoorian A Krycer JR Fazakerley DJ Burchfield JG James DE	31548312	J Biol Chem	2019
Serine 380 (P14) --> glutamate mutation activates antithrombin as an inhibitor of factor Xa.	Futamura A Gettins PG	10660568	J Biol Chem	2000
Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase.	Copps KD Hançer NJ Qiu W White MF	26846849	J Biol Chem	2016
Serglycin-independent release of active mast cell proteases in response to Toxoplasma gondii infection.	Sawesi O Spillmann D Lundén A Wernersson S Åbrink M	20864536	J Biol Chem	2010
Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.	Purushothaman A Toole BP	24403068	J Biol Chem	2014
Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1.	Meen AJ Øynebråten I Reine TM Duelli A Svennevig K Pejler G Jenssen T Kolset SO	21075844	J Biol Chem	2011
Serglycin expression during monocytic differentiation of U937-1 cells.	Kulseth MA Mustorp SL Uhlin-Hansen L Oberg F Kolset SO	9639535	Glycobiology	1998
Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro.	Theocharis AD Seidel C Borset M Dobra K Baykov V Labropoulou V Kanakis I Dalas E Karamanos NK Sundan A Hjerpe A	16870619	J Biol Chem	2006

Download data in CSV format Download data in TSV format Download data in JSON format

Table Filtering

GlyTouCan

GlyComb

GlycoPOST

UniCarb-DR

All Resources

Other Information

Tools

Search Tools

International Collaboration

Acknowledgements